Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTO.L Regulatory News (CTO)

  • There is currently no data for CTO

Trading Statement

26 Nov 2020 07:00

RNS Number : 5273G
TClarke PLC
26 November 2020
 

 

 

 

TClarke plc

 

TRADING UPDATE

 

ORDER BOOK STRENGTHENS AT TCLARKE AS MARGINS MAINTAINED

 

TClarke plc ("TClarke" or the "Group"), the Building Services Group, today issues a trading update for the period from 1 October 2020 to date.

 

2020 trading update

 

The Group is pleased to report that it continues to trade in line with expectations for the full year ending 31 December 2020. The Board is encouraged by the resilient performance that the Group has delivered.

As stated previously, we anticipate turnover for 2020 to be circa £240m and underlying EBIT (EBIT) to be approximately £6m. TClarke achieved its target 3% EBIT margin in Q1, broke even on much reduced volumes in Q2 and expects to deliver a 3% margin for H2.

During the second half of the year, TClarke has been successful in winning new projects from clients across a wide range of sectors. Our forward order book has increased to £422m. This is a significant result for the Group and is £61m (17%) higher than at the same point in 2019. Reassuringly, revenues of £257m for 2021 have already been secured, against an equivalent figure of £232m at this time last year and up from £191m when we announced the Group's interim results in August. This is testament to our strong reputation among our clients and we have been consistent in maintaining our strict tendering assessments, to ensure that we are accepting work that meets our margin expectations.

 

In addition, TClarke is pleased to be assisting with the rapid delivery of COVID-19 Testing Stations across the UK. New Test Centres are constructed within 24 Hours and our teams across the country are assisting with maintenance of the sites when in use.

 

Outlook

 

TClarke has demonstrated its resilience and agility during 2020. As a Board, we are grateful to all the TClarke team for their hard work and dedication during this challenging period.

 

Looking beyond 2020 our proven strategy remains to focus on projects and markets that meet our margin and growth criteria. The strategy we have followed has resulted in TClarke being particularly strong in the healthcare, education and data centre market sectors, whilst continuing to serve the commercial office market.

 

We have exciting opportunities across all of these market sectors, providing excellent opportunities for growth over the next few years.

 

TClarke approaches the new financial year in a strong position, both operationally and financially.

 

Commenting, Mark Lawrence, TClarke CEO said,

 

" TClarke has once again demonstrated the direct benefits of our excellent reputation within our industry that has helped drive our clients' continued confidence to work with us and award the Group significant new projects.

 

Looking to the future, we have a well-balanced approach to winning work with projects from a range of sectors and I am delighted that we have been so successful in the Healthcare and Technology sectors in particular.

 

The UK Government recently announced a long-term commitment to developing further green initiatives covering clean energy, transport, nature and innovative technologies, that will help the UK to forge ahead with eradicating its contribution to climate change by 2050. TClarke is well positioned to benefit from these initiatives and is already working on a wide range of exciting projects that support these moves."

 

 

Date: 26th November 2020

 

For further information contact:

 

 

TClarke plcMark Lawrence

Group Chief Executive

Trevor Mitchell

Finance Director Tel: 020 7997 7400

www.tclarke.co.uk

 

Cenkos Securities plc (Corporate Broker)

Max Hartley (Corporate Finance)

Nick Searle (Sales)

Tel: 020 7397 8900

www.cenkos.com

 

RMS Partners

Simon Courtenay

Tel: 020 3735 6551

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPGWUGUPUGQA
Date   Source Headline
29th Jun 20227:00 amRNSNotice of Investor Presentation
23rd Jun 202210:45 amRNSNotice of Results
22nd Jun 20222:46 pmRNSChange of Auditor
22nd Jun 20229:37 amRNSTotal Voting Rights
17th May 20227:00 amRNSTClarke to Present at Mello Investor Conference
11th May 202210:27 amRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
10th May 202212:51 pmRNSESOT Share Purchase
5th May 20223:52 pmRNSESOT Share Purchase
3rd May 20229:03 amRNSDirector/PDMR Shareholding
26th Apr 20224:29 pmRNSVesting of EIP share awards April 2022
20th Apr 20229:27 amRNSChange of Registered Office
8th Apr 202210:09 amRNSPublication of Annual Report and Notice of AGM
8th Apr 20227:00 amRNSDirectorate Change
16th Mar 20228:27 amRNSDirector/PDMR Shareholding
16th Mar 20228:21 amRNSTotal Voting Rights
11th Mar 20227:00 amRNSInvestor Presentation
9th Mar 20227:02 amRNSDirectorate Change
9th Mar 20227:00 amRNSNotification of Investor Presentation
9th Mar 20227:00 amRNSFinal Results
2nd Feb 20223:21 pmRNSTotal Voting Rights
1st Feb 20227:00 amRNSNotification of Investor Presentation
27th Jan 20227:00 amRNSTrading Statement
4th Jan 202211:28 amRNSBlock listing Interim Review
9th Dec 20211:11 pmRNSESOT Share Purchase
6th Dec 20219:40 amRNSESOT Share Purchase
3rd Dec 202111:51 amRNSTR-1: Notification of Change of Holding
1st Dec 20213:02 pmRNSPDMR Disclosure
1st Dec 20213:00 pmRNSTotal Voting Rights and Share Capital
25th Nov 20217:00 amRNSTrading Statement
18th Oct 20217:00 amRNSInvestor Presentation
6th Oct 202111:14 amRNSPDMR Holding
6th Oct 202111:10 amRNSBlock Listing Application
22nd Sep 20217:00 amRNSNotice of Investor Presentation
17th Aug 20211:41 pmRNSDirector/PDMR Shareholding
9th Aug 20217:00 amRNSTClarke Selected for NHS Smart Buildings Framework
20th Jul 20217:00 amRNSHalf-year Report
5th Jul 20217:00 amRNSBlock listing Interim Review
1st Jul 20217:00 amRNSNotice of Results
1st Jul 20217:00 amRNSTotal Voting Rights
6th May 20219:04 amRNSTR-1: Notification of major holding in Company
5th May 202111:20 amRNSResult of AGM
5th May 20217:01 amRNSDirectorate Change
5th May 20217:00 amRNSAGM - Trading Update
29th Apr 20217:00 amRNSDirector / PDMR Shareholding
28th Apr 20217:00 amRNSDirector / PDMR Shareholding
12th Apr 202110:40 amRNSESOT Share Purchase
9th Apr 20212:53 pmRNSPublication of Annual Report & Notice of 2021 AGM
6th Apr 202110:39 amRNSESOT Share Purchase
26th Mar 20212:28 pmRNSESOT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.